Minimum alveolar concentration of halogenated volatile anaesthetics in left ventricular hypertrophy and congestive heart failure in rats

British Journal of Anaesthesia

Volumn 99, Issue 6, 2007, Pages 787-793

  Barbry, T ^a   Le Guen, M ^a   De Castro, V ^a   Coriat, P ^a   Riou, B ^a   Vivien, B ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anaesthetics volatile isoflurane; Anaesthetics volatile, halothane; Anaesthetics volatile, sevaflurane; Heart, myocardial function; Potency, anaesthetic, MAC

Indexed keywords

HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE; ETHER DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA STENOSIS; ARTICLE; BREATHING; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG POTENCY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTROPHIC CARDIOMYOPATHY; LOGISTIC REGRESSION ANALYSIS; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DISEASE COURSE; DOSE RESPONSE; HEART FAILURE; LUNG ALVEOLUS; METABOLISM; WISTAR RAT;

ANESTHETICS, INHALATION; ANIMALS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOTHANE; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; ISOFLURANE; MALE; METHYL ETHERS; PULMONARY ALVEOLI; RATS; RATS, WISTAR;

EID: 38449100819     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem292     Document Type: Article

References (44)

1. Hettrick DA, Pagel PS, Kersten JR, Lowe D, Warltier DC. The effects of isoflurane and halothane on left ventricular afterload in dogs with dilated cardiomyopathy. Anesth Analg 1997; 85: 979-86
2. Hanouz JL, Massetti M, Guesne G, et al. In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. Anesthesiology 2000; 92: 116-24
3. Hanley PJ, ter Keurs HE, Cannell MB. Excitation-contraction coupling in the heart and the negative inotropic action of volatile anesthetics. Anesthesiology 2004; 101: 999-1014
4. David JS, Tavernier B, Amour J, Vivien B, Coriat P, Riou B. Myocardial effects of halothane and sevoflurane in diabetic rats. Anesthesiology 2004; 100: 1179-87
5. Preckel B, Müllenheim J, Hoff J, et al. Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. Eur J Anaesthesiol 2004; 21: 797-806
6. Antognini JF, Carstens E. Measuring minimum alveolar concentration: more than meets the tail. Anesthesiology 2005; 103: 679-80
7. Vitez TS, White PF, Eger EI, II. Effects of hypothermia on halothane MAC and isoflurane MAC in the rat. Anesthesiology 1974; 41: 80-1
8. Stevens WD, Dolan WM, Gibbons RT, et al. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975; 42: 197-200
9. Mazze RI, Rice SA, Baden JM. Halothane, isoflurane, and enflurane MAC in pregnant and nonpregnant female and male mice and rats. Anesthesiology 1985; 62: 339-41
10. Brian JE Jr, Bogan L, Kennedy RH, Seifen E. The impact of streptozotocin-induced diabetes on the minimum alveolar anesthetic concentration (MAC) of inhaled anesthetics in the rat. Anesth Analg 1993; 77: 342-5
11. Gill R, Martin C, McKinnon T, Lam C, Cunningham D, Sibbald WJ. Sepsis reduces isoflurane MAC in a normotensive animal model of sepsis. Can J Anaesth 1995; 42: 631-5
12. Allaouchiche B, Duflo F, Tournadre JP, Debon R, Chassard D. Influence of sepsis on sevoflurane minimum alveolar concentration in a porcine model. Br J Anaesth 2001; 86: 832-6
13. Vivien B, Langeron O, Coriat P, Riou B. Minimum alveolar anesthetic concentration of volatile anesthetics in normal and cardiomyopathic hamsters. Anesth Analg 1999; 88: 489-93
14. Miyamoto MI, del Monte F, Schmidt U, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2000; 97: 793-8
15. Moreira VO, de Castro AV, Yaegaschi MY, et al. Echocardiographic criteria for the definition of ventricular dysfunction severity in aortic banded rats. Arq Bras Cardiol 2006; 86: 432-8
16. De Simone G, Wallerson DC, Volpe M, Devereux RB. Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens 1990; 3: 688-96
17. Pawlush DG, Moore RL, Musch TI, Davidson WR Jr. Echocardiographic evaluation of size, function, and mass of normal and hypertrophied rat ventricles. J Appl Physiol 1993; 74: 2598-605
18. Sjaastad I, Sejersted OM, Ilebekk A, Bjornerheim R. Echocardiographic criteria for detection of postinfarction congestive heart failure in rats. J Appl Physiol 2000; 89: 1445-54
19. Rozenberg S, Besse S, Amour J, Vivien B, Tavernier B, Riou B. Effects of desflurane in senescent rat myocardium. Anesthesiology 2006; 105: 961-7
20. Eger EI, II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965; 26: 756-63
21. White PF, Johnston RR, Eger EI, II. Determination of anesthetic requirement in rats. Anesthesiology 1974; 40: 52-7
22. Orliaguet G, Vivien B, Langeron O, Bouhemad B, Coriat P, Riou B. Minimum alveolar concentration of volatile anesthetics in rats during postnatal maturation. Anesthesiology 2001; 95: 734-9
23. Munson ES, Martucci RW, Smith RE. Circadian variations in anesthetic requirement and toxicity in rats. Anesthesiology 1970; 32: 507-14
24. Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI. Renal effects and metabolism of sevoflurane in Fisher 344 rats: an in-vivo and in-vitro comparison with methoxyflurane. Anesthesiology 1975; 43: 70-7
25. Zbinden AM, Maggiorini M, Petersen-Felix S, Lauber R, Thomson DA, Minder CE. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. I. Motor reactions. Anesthesiology 1994; 80: 253-60
26. Stanski DR. Monitoring depth of anesthesia. In: Miller RD, ed., Anesthesia, 4th Edn. New York: Churchill Livingstone, 1994; 1127-259
27. Iltis I, Kober F, Dalmasso C, Lan C, Cozzone PJ, Bernard M. In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia. J Magn Reson Imaging 2005; 22: 242-7
28. Barter LS, Ilkiw JE, Steffey EP, Pypendop BH, Imai A. Animal dependence of inhaled anaesthetic requirements in cats. Br J Anaesth 2004; 92: 275-7
29. Jinks SL, Martin JT, Carstens E, Jung SW, Antognini JF. Peri-MAC depression of a nociceptive withdrawal reflex is accompanied by reduced dorsal horn activity with halothane but not isoflurane. Anesthesiology 2003; 98: 1128-38
30. Rioja E, Santos M, Martinez Taboada F, Ibancovichi JA, Tendillo FJ. Cardiorespiratory and minimum alveolar concentration sparing effects of a continuous intravenous infusion of dexmedetomidine in halothane or isoflurane-anaesthetized rats. Lab Anim 2006; 40: 9-15
31. Wilkes AR, Raj N, Hall JE. Adverse airway events during brief nasal inhalations of volatile anaesthetics: the effect of humidity and repeated exposure on incidence in volunteers pre-selected by response to desflurane. Anaesthesia 2003; 58: 207-16
32. Tanifuji Y, Eger EI, II. Effect of arterial hypotension on anaesthetic requirement in dogs. Br J Anaesth 1976; 48: 947-52
33. Quasha AL, Eger EI, II, Tinker JH. Determination and applications of MAC. Anesthesiology 1980; 53: 315-34
34. Steffey EP, Eger EI. The effect of seven vasopressors of halothane MAC in dogs. Br J Anaesth 1975; 47: 435-8
35. Davila DF, Donis JH, Bellabarba G, Torres A, Casado J, Mazzei de Davila C. Cardiac afferents and neurohormonal activation in congestive heart failure. Med Hypotheses 2000; 54: 242-53
36. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand 2003; 177: 17-26
37. Himura Y, Liang CS, Imai N, Delehanty JM, Woolf PD, Hood WB Jr. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure. J Am Coll Cardiol 1994; 23: 194-200
38. Fontana F, Bernardi P, Pich EM, Boschi S, De Iasio R, Spampinato S. Endogenous opioid peptides and mental stress in congestive heart failure patients. Peptides 1998; 19: 21-6
39. Dahan A, Sarton E, Teppema L, et al. Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice. Anesthesiology 2001; 94: 824-32
40. Hao S, Takahata O, Mamiya K, Iwasaki H. Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems. Life Sci 2002; 71: 571-80
41. Lylyk P, Vila JF, Miranda C, Ferrario A, Romero R, Cohen JE. Partial aortic obstruction improves cerebral perfusion and clinical symptoms in patients with symptomatic vasospasm. Neurol Res 2005; 27: S129-35
42. Matta BF, Heath KJ, Tipping K, Summors AC. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology 1999; 91: 677-80
43. Lecarpentier Y, Chemla D, Blanc FX, et al. Mechanics, energetics, and crossbridge kinetics of rabbit diaphragm during congestive heart failure. FASEB J 1998; 12: 981-9
44. Vivien B, David JS, Hanouz JL, et al. The paradoxical positive inotropic effect of sevoflurane in healthy and cardiomyopathic hamsters. Anesth Analg 2002; 95: 31-8